Korean J Hematol.  2006 Mar;41(1):56-60. 10.5045/kjh.2006.41.1.56.

Triplication of 1q in a Patient with Myelodysplastic Syndrome

• Cho HS
• Kim MK
• Hyun MS

• KMID: 2252329
• DOI: http://doi.org/10.5045/kjh.2006.41.1.56

Abstract

Triplication of 1q is a very rare chromosomal abnormality in hematologic malignancies, and it has been related to Fanconi anemia. The clinical significance of this abnormality is unknown. We report here on a 55-year-old female patient who had myelodysplastic syndrome (refractory anemia with excess blasts) with triplication of 1q and trisomy 8 as the clonal cytogenetic abnormalities, as determined by bone marrow cytogenetic analysis. However, there were no clinical manifestations of Fanconi anemia or any chromosomal instability according to the peripheral blood chromosomal breakage testing. The patient developed early gastric carcinoma (poorly differentiated adenocarcinoma with a signet ring cell component) eight months later. She continuously had pancytopenia with dysplastic features, but this showed no evidence of evolving to leukemia or any relapse of the gastric carcinoma over a 2 year follow up.

Keyword

Triplication of 1q; Myelodysplastic syndrome; Fanconi anemia

MeSH Terms

Adenocarcinoma
Anemia
Bone Marrow
Chromosomal Instability
Chromosome Aberrations
Chromosome Breakage
Cytogenetic Analysis
Fanconi Anemia
Female
Follow-Up Studies
Hematologic Neoplasms
Humans
Leukemia
Middle Aged
Myelodysplastic Syndromes*
Pancytopenia
Recurrence
Trisomy

Figure

• 

  Fig. 1 The bone marrow aspirate showed dysplastic features and increase of blasts (Wright stain, ×1,000).

• 

  Fig. 2 The representative karyotype of bone marrow shows 47,XX,trp(1)(q21q32),+8.

• 

  Fig. 3 The karyotype of peripheral blood shows normal female karyotype.

Reference

1). Brunning RD., Bennett JM., Flandrin G, et al. Myelo-dysplastic syndromes. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours: tumours of haematopoietic and lymphoid tissues. Lyon, France: IARS Press;2001. p. 61–73.

2). Andrieux J., Demory JL., Caulier MT, et al. Karyotypic abnormalities in myelofibrosis following polycythemia vera. Cancer Genet Cytogenet. 2003. 140:118–23.

3). Knuutila S., Ruutu T., Partanen S., Vuopio P. Chromosome 1q+ in erythroid and granulocyte-monocyte precursors in a patient with essential thrombocythemia. Cancer Genet Cytogenet. 1983. 9:245–9.

4). Lee DS., Kim SH., Seo EJ, et al. Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study. Cancer Genet Cytogenet. 2002. 132:97–101.

5). Auerbach AD., Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet. 1991. 51:1–12.

6). Maarek O., Jonveaux P., Le Coniat M., Derre J., Berger R. Fanconi anemia and bone marrow clonal chromosome abnormalities. Leukemia. 1996. 10:1700–4.

7). Ferro MT., Vazquez-Mazariego Y., Ramiro S, et al. Triplication of 1q in Fanconi anemia. Cancer Genet Cytogenet. 2001. 127:38–41.

8). Papenhausen PR., Wolkin-Friedman E., Pekzar-Wissner C. Novel tandem triplication of 1q in a patient with a myelodysplastic syndrome. Cancer Genet Cytogenet. 1984. 12:145–50.

9). Petkovic I., Nakic M., Tiefenbach A, et al. Marker chromosome 1q+ in acute lymphocytic leukemia. Cancer Genet Cytogenet. 1987. 24:251–5.

10). Schindler D., Kubbies M., Hoehn H., Schinzel A., Rabinovitch PS. Confirmation of Fanconi's anemia and detection of a chromosomal aberration (1Q12-32 triplication) via BrdU/Hoechst flow cytometry. Am J Pediatr Hematol. 1987. 9:172–7.

11). Berger R., Le Coniat M., Schaison G. Chromosome abnormalities in bone marrow of Fanconi anemia patients. Cancer Genet Cytogenet. 1993. 65:47–50.

12). Raimondi SC., Pui CH., Hancock ML., Behm FG., Filatov L., Rivera GK. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia. 1996. 10:213–24.

13). Sawyer JR., Lukacs JL., Munshi N, et al. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood. 1998. 92:4269–78.

14). Cook JR., Shekhter-Levin S., Swerdlow SH. Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies. Am J Clin Pathol. 2004. 121:826–35.

15). Brown MG., Lawce HJ. Peripheral blood cytogenetic methods. Barch MJ, Knutsen T, Spurbeck J, editors. The AGT cytogenetics laboratory manual. 3rd ed.Philadelphia, USA: Lipphincott-Raven Publishers;1997. p. 77–171.

16). Olah E., Balogh E., Kovacs I., Kiss A. Abnormalities of chromosome 1 in relation to human malignant diseases. Cancer Genet Cytogenet. 1989. 43:179–94.

17). Fonatsch C., Haase D., Freund M., Bartels H., Tesch H. Partial trisomy 1q. A nonrandom primary chromosomal abnormality in myelodysplastic syndromes? Cancer Genet Cytogenet. 1991. 56:243–53.

18). Djordjevic V., Jankovic G., Suvajdzic N, et al. A der(14)t(1;14)(q12;p11) in chronic myelomonocytic leukemia. Cancer Genet Cytogenet. 2005. 160:89–93.